Cargando…
The Effect of Teprotumumab on Eyelid Position in Patients with Thyroid Eye Disease
Teprotumumab has been shown to improve proptosis and clinical activity scores (CAS) in patients with thyroid eye disease, but little has been published regarding its effects on eyelid retraction. The purpose of this work was to evaluate changes in eyelid position in thyroid eye disease patients afte...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029877/ https://www.ncbi.nlm.nih.gov/pubmed/35475287 http://dx.doi.org/10.1097/GOX.0000000000004287 |